Jane L. Liesveld, M.D.

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, New York 14642

Office: 585 275-4099

Fax: 585 27t-5590

Effects of oxygen metabolites/chemokines on hematopoietic stem cell expansion and preservation.

Effects of hematopoietic growth factors and inhibitors on AML blast proliferation (correlative clinical studies)

Effects of hematopoietic stem cell adhesion on marrow stromal cell cytokine production.

Role of signal transduction inhibition in treatment of acute myelogenous leukemia/myelodysplasia.

Characterization of mobilized peripheral blood stem cells

Current Appointments

Education
MD Medicine University Iowa Coll Medicine 1980
BS Arts & Sciences University of Iowa 1976
Post-Doctoral Training & Residency
Hematology Research Fellowship  University of Rochester School of Medicine & Dentistry, Rochester, NY 1988 - 1989
Medical Oncology Fellowship  University of Rochester School of Medicine & Dentistry, Rochester, NY 1987 - 1988
Hematology Fellowship - University of Rochester School of Medicine & Dentistry, Rochester, NY 1984 - 1987
Chief Resident & Instructor in Medicine - St. Mary's Hospital, University of Rochester School of Medicine & Dentistry, Rochester, NY 1983 - 1984
Residency - Internal Medicine, Strong Memorial Hospital, University of Rochester School of Medicine & Dentistry, Rochester, NY 1981 - 1983
Internship - Internal Medicine, Strong Memorial Hospital, University of Rochester School of Medicine & Dentistry, Rochester, NY 1980 - 1981
Recent Journal Articles
Showing the 5 most recent journal articles. (100 available)
Rana K; Liesveld JL; King MR. "Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin." Biotechnology and bioengineering. 2009; 102(6):1692-702.
Dhakal S; Biswas T; Liesveld JL; Friedberg JW; Phillips GL; Constine LS. "Patterns and Timing of Initial Relapse in Patients Subsequently Undergoing Transplantation for Hodgkin's Lymphoma." International journal of radiation oncology, biology, physics. 2009; Epub 2009 Feb 26.
Mustjoki S; Ekblom M; Arstila TP; Dybedal I; Epling-Burnette PK; Guilhot F; Hjorth-Hansen H; Höglund M; Kovanen P; Laurinolli T; Liesveld J; Paquette R; Pinilla-Ibarz J; Rauhala A; Shah N; Simonsson B; Sinisalo M; Steegmann JL; Stenke L; Porkka K. "Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy." Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2009; Epub 2009 Mar 19.
Brown JR; Friedberg JW; Feng Y; Scofield S; Phillips K; Dal Cin P; Joyce R; Takvorian RW; Fisher DC; Fisher RI; Liesveld J; Marquis D; Neuberg D; Freedman AS. "A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas." British journal of haematology. 2009; Epub 2009 Mar 27.
Dugan MJ; Maziarz RT; Bensinger WI; Nademanee A; Liesveld J; Badel K; Dehner C; Gibney C; Bridger G; Calandra G. "Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization." Bone marrow transplantation. 2009; Epub 2009 Jun 01.